MacroGenics | MGNX - Equity Capital And Reserves

Stock Price
1.98
Daily Change
0.06 3.13%
Monthly
7.61%
Yearly
-17.50%
Q1 Forecast
1.65

MacroGenics reported $67M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
AbbVie USD -3.27B 628M Dec/2025
Amgen USD 8.66B 961M Dec/2025
AstraZeneca USD 48.67B 2.78B Dec/2025
Biogen USD 18.21B 573.5M Sep/2025
Bristol-Myers Squibb USD 18.55B 1.06B Sep/2025
Daiichi Sankyo JPY 1.71T 57.86B Dec/2025
Eli Lilly USD 26.54B 2.74B Dec/2025
Genmab DKK 5.3B 6M Jun/2025
Geron USD 248.71M 10.82M Sep/2025
Gilead Sciences USD 22.62B 1.16B Dec/2025
J&J USD 78.47B 0 Sep/2025
Karyopharm Therapeutics USD -269.26M 30.33M Sep/2025
MacroGenics USD 67M 20.38M Sep/2025
Merck USD 51.85B 2.79B Sep/2025
Pfizer USD 92.8B 4.11B Sep/2025
Puma Biotechnology USD 115.27M 10.55M Sep/2025
Regeneron Pharmaceuticals USD 31.26B 299.1M Dec/2025
Roche Holding CHF 33.8B 758M Dec/2025
Xencor USD 635.59M 10.27M Dec/2025